|
About Ed Francis
DistilNFO's Executive Editor & Senior Industry Strategist.
Ed is the National Life Sciences Practice lead for West Monroe Partners & has more than 20 years of management consulting experience guiding some of the industry’s most prominent organizations. Subscribe to the Newsletter Here |
|
Advanced information technologies in medical devices have transformed the healthcare industry, bringing improvements in the efficiency and effectiveness of treatment and other services. However, these advanced devices provide opportunities ...
|
|
|
|
Artificial intelligence (AI) technology, combined with automatically collected big data hold the potential to solve many key clinical trial challenges. These include increasing trial efficiency through better protocol design, patient enroll...
|
|
|
|
Developing new medicines isn’t for the faint of heart. On average, it takes about a decade of research — and an expenditure of $2.6 billion — to shepherd an experimental drug from lab to market. And because of concerns over safety an...
|
|
|
|
The FDA has placed a clinical hold on Ziopharm Oncology’s phase 1 CAR-T trial. Ziopharm wants to run the study to assess CAR-T cells manufactured at the point of care, but the FDA is demanding more chemistry, manufacturing and control ...
|
|
|
|
As the clinical trial landscape becomes more costly, complex and time consuming, operational teams are turning to technology to help gain more insights from the massive amounts of clinical trial data. Data, Risk and Technology in Clinical ...
|
|
|
|
Fewer than 8 percent of clinical trial participants felt that security and privacy risks of health data sharing outweighed the benefits, according to a study by Stanford researchers recently published in the New England Journal of Medicine....
|
|
|
|
Problems with seasonal flu shots have been well documented, and now U.K. biotech Imutex believes it has the next big advance for flu vaccine technology. The company this week reported phase 2b data showing that its universal flu ...
|
|
|
|
Medical devices are proliferating throughout the healthcare landscape, especially with the advent of the Internet of Things and the myriad new products that come with it. The medical device ...
|
|
|
|
By now many of you have grown tired of hearing about how the Internet of Things will change our lives. For the last few years, ever since the term “Industry 4.0” hit the scene at Hannover Messe Fair in 2011, we have been waiting for the...
|
|
|
|
The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs. To justify the costs of drug development, most pharmaceutical companies aim to develop 2-3 new drugs per year, but ...
|
|
|
|
Advertise with us
We Reach Quarter Million Decision Makers in: Healthcare | IT | Retail | Industrial Advertise with us and reach the right audience.
|